Abstract:Georges Abi Abdallah, 1 Sylvain Diop, 2 Matthieu Jamme, 3, 4 Stéphane Legriel, 1, 5 Alexis Ferré 1 1 Intensive Care Unit, Versailles Hospital, Le Chesnay, France; 2 Cardiothoracic Intensive Care Unit, Department of Anesthesiology, Marie Lannelongue Hospital, Le Plessis Robinson, France; 3 Service de Réanimation Polyvalente, Hôpital Privé de l'Ouest Parisien, Ramsay-Générale de Santé, Trappes, France; 4 CESP, INSERM U1018, Equipe Epidémiologie Clinique, Villejuif, France; 5 University Paris-Saclay, UVSQ, INSERM, CESP, Team "PsyDev", Villejuif, France Correspondence: Georges Abi Abdallah, Intensive Care Unit, Versailles Hospital, 177 Rue de Versailles, Le Chesnay, 78150, France, Email Background: Data are scarce on respiratory infections during severe acute exacerbation of chronic obstructive pulmonary disease (COPD). This study aimed to investigate respiratory infection patterns in the intensive care unit (ICU) and identify variables associated with infection type and patient outcome. Methods: A retrospective, single-centre cohort study. All patients admitted (2015– 2021) to our ICU for severe acute exacerbation of COPD were included. Logistic multivariable regression analysis was performed to predict factors associated with infection and assess the association between infection and outcome. Results: We included 473 patients: 288 (60.9%) had respiratory infection and 139 (29.4%) required invasive mechanical ventilation. Eighty-nine (30.9%) had viral, 81 (28.1%) bacterial, 34 (11.8%) mixed, and 84 (29.2%) undocumented infections. Forty-seven (9.9%) patients died in the ICU and 67 (14.2%) in hospital. Factors associated with respiratory infection were temperature (odds ratio [+1°C]=1.43, P= 0.008) and blood neutrophils (1.07, P= 0.002). Male sex (2.21, P= 0.02) and blood neutrophils were associated with bacterial infection (1.06, P= 0.04). In a multivariable analysis, pneumonia (cause-specific hazard=1.75, P= 0.005), respiratory rate (1.17, P =0.04), arterial partial pressure of carbon-dioxide (1.08, P= 0.04), and lactate (1.14, P= 0.02) were associated with the need for invasive MV. Age (1.03, P= 0.03), immunodeficiency (1.96, P= 0.02), and altered performance status (1.78, P= 0.002) were associated with hospital mortality. Conclusions: Respiratory infections, 39.9% of which were bacterial, were the main cause of severe acute exacerbation of COPD. Body temperature and blood neutrophils were single markers of infection. Pneumonia was associated with the need for invasive mechanical ventilation but not with hospital mortality, as opposed to age, immunodeficiency, and altered performance status. Plain Language Summary: - This study investigates the prevalence, characteristics, and impact on outcomes of different types of respiratory infections triggering severe acute exacerbations of COPD.- Our retrospective cohort study of 473 critically ill patients found that respiratory infections, of which 39.9% were bacterial, were the main cause of severe exacerbation.- The type of infection (viral, bacterial, or mixt) was not associated with the need for invasive mechanical ventilation or mortality.- Early identification of the infectious agent is crucial for implementing effective therapy; however, the type of infection was not associated with the main outcomes. Keywords: pneumonia, infection, COPD, mechanical ventilation, mortality Exacerbation of chronic obstructive pulmonary disease (COPD) presents as a transient increase in respiratory symptoms, 1 with acute severe exacerbations requiring hospitalization. These events increase short- and mid-term morbidity and mortality, especially in the most severe cases when ventilatory support is mandatory. 2 Despite improved management in the intensive care unit (ICU), severe acute exacerbations are associated with a high mortality rate (20%) at hospital discharge. 3 Identifying exacerbation triggers in individual patients is a major issue in the ICU. Respiratory infections are the main cause of COPD exacerbation. 4 Recent literature from the ICU provides limited information on the characteristics and impact of the viral or bacterial nature of the infection, even though the therapeutic issue is of primary importance in this context. 5,6 Moreover, assessing the association between respiratory infections and the use of invasive mechanical ventilation (MV) and mortality seems relevant and could be an axis for improving management in the acute phase. The main objectives of this study were to describe, evalu -Abstract Truncated-

Prognosis of critically ill immunocompromised patients with virus-detected acute respiratory failure

Clinical characteristics and outcomes of respiratory syncytial virus-associated ARF in immunocompetent patients: A seven-year experience at a tertiary hospital in France

Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study

Acute respiratory failure in immunocompromised adults

Severe Community-Acquired Pneumonia in Immunocompromised Patients

Comparison of mortality and outcomes of four respiratory viruses in the intensive care unit: a multicenter retrospective study

Severe Infections Due to Respiratory Viruses

Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study

Respiratory Infection Triggering Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study

Clinical practice of respiratory virus diagnostics in critically ill patients with a suspected pneumonia: A prospective observational study

Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study

Assessment of respiratory support decision and the outcome of invasive mechanical ventilation in severe COVID-19 with ARDS

Use of Noninvasive Ventilation in Immunocompromised Patients with Acute Respiratory Failure: A Systematic Review and Meta-Analysis

Epidemiology and clinical impact of viral, atypical, and fungal respiratory pathogens in symptomatic immunocompromised patients: a two-center study using a multi-parameter customized respiratory Taqman® array card

How I Manage Acute Respiratory Failure in Patients with Hematological Malignancies

Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study

The Extent of Aspergillosis in Critically Ill Patients With Severe Influenza Pneumonia: A Multicenter Cohort Study

One year after ICU admission for severe community-acquired pneumonia of bacterial, viral or unidentified etiology. What are the outcomes?

Impact of respiratory viral infections on mortality and critical illness among hospitalized patients with chronic obstructive pulmonary disease

Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study